Dolutegravir Clinical Trials
5 recruitingDrug
Phase 12Phase 41Phase 21Phase 31
Showing 1–5 of 5 trials
Recruiting
Phase 2
Early Metabolic Effects of Antiretroviral Drugs in Healthy volUnteers: a Phase 2 Randomized Study
Weight GainHealthy VolunteerMetabolic Effects+1 more
National Institute of Allergy and Infectious Diseases (NIAID)120 enrolled1 locationNCT05652478
Recruiting
Phase 1
A Clinical Trial of MK-4646 With Bictegravir/Emtricitabine/Tenofovir Alafenamide and Dolutegravir in Healthy Adult Participants (MK-4646)
Healthy
Merck Sharp & Dohme LLC16 enrolled1 locationNCT07532304
Recruiting
Phase 4
Doravirine Dose Optimisation in Pregnancy
HIV
University of Liverpool76 enrolled1 locationNCT05630638
Recruiting
Phase 1
Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention
Pediatric HIV InfectionLatent Tuberculosis
Brigham and Women's Hospital25 enrolled1 locationNCT06281834
Recruiting
Phase 3
Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch
HIV-1-infection
Chelsea and Westminster NHS Foundation Trust150 enrolled3 locationsNCT04892654